-
1 Comment
Dian Diagnostics Group Co.,Ltd is currently in a long term downtrend where the price is trading 8.2% below its 200 day moving average.
From a valuation standpoint, the stock is 76.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Dian Diagnostics Group Co.,Ltd's total revenue rose by 35.4% to $3B since the same quarter in the previous year.
Its net income has increased by 283.5% to $398M since the same quarter in the previous year.
Finally, its free cash flow grew by 179.6% to $289M since the same quarter in the previous year.
Based on the above factors, Dian Diagnostics Group Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE1000015N1 |
| Market Cap | 9B |
|---|---|
| PE Ratio | None |
| Dividend Yield | 6.5% |
| Target Price | 12.82 |
| Beta | 0.47 |
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pahtology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services. It also provides DP-TOF nucleic acid mass spectrometry solutions, including mass spectroscopy system, automatic sample processing system, respiratory pathogens multiple detection kit, and nucleic acid sample pretreatment reagent kit; and forensic drug testing products comprises diangio, hair drug trace tester and detector, and saliva and urine drug testing product series. In addition, the company provides supply chain optimization, information management, cold chain logistics, intelligent warehousing, sample library management, scientific research services, etc., as well as solutions for laboratory quality. It is involved in the research, development of diagnostic products and vitro diagnostic reagents, as well as forensic identification, health management, and other fields. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300244.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
